We are live on ! Find out more
AONCW

American Oncology Network, Inc. Warrant
AONCW

Delisted

AONCW was delisted on the 7th of June, 2024.

Back to rankings

45 hedge funds and large institutions have $5.19M invested in American Oncology Network, Inc. Warrant in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

22% more funds holding

Funds holding: 37 → 45 (+8)

1% less capital invested

Capital invested by funds: $5.24M → $5.19M (-$44K)

Holders
45
Holders Change
+8
Holders Change %
+21.62%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
4
Reduced
2
Closed
2
Calls
$3.14M
Puts
–
Net Calls
+$3.14M
Net Calls Change
-$138K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$126K
2
SRF
Silver Rock Financial
California
+$121K
3
RA
Ramius Advisors
New York
+$92K
4
HI
HBK Investments
Texas
+$90.5K
5
PC
Periscope Capital
Ontario, Canada
+$39K

Top Sellers

Rank Fund Capital Flow
1
AC
Athanor Capital
New York
-$702K
2
GCL
Glazer Capital LLC
New York
-$82.6K
3
BCM
BlueCrest Capital Management
Jersey
-$70K
4
UBS Group
UBS Group
Switzerland
-$448
Name Holding Trade Value Shares
Change 		Change in
Stake
VI
26
Vestcor Inc
New Brunswick, Canada
$33K – – –
KLM
27
Kennedy Lewis Management
New York
$33K +$33.5K +50,000 New
QGA
28
Q Global Advisors
Texas
$33K +$33.5K +50,000 New
WA
29
Whitebox Advisors
Minnesota
$33K +$33.5K +50,000 New
CCA
30
Castle Creek Arbitrage
Colorado
$31K – – –
PCM
31
Prelude Capital Management
New York
$27K +$1.47K +2,193 +6%
SCC
32
Spring Creek Capital
Kansas
$26K – – –
CCM
33
Context Capital Management
California
$25K – – –
DCP
34
Diameter Capital Partners
New York
$25K +$25.1K +37,500 New
PAMP
35
Polar Asset Management Partners
Ontario, Canada
$23K – – –
AA
36
Ancora Advisors
Ohio
$20K – – –
CCM
37
CAAS Capital Management
New York
$20K – – –
Balyasny Asset Management
38
Balyasny Asset Management
Illinois
$16K – – –
OCAM
39
Owl Creek Asset Management
New York
$16K – – –
VAS
40
VR Advisory Services
Cayman Islands
$13K +$14.8K +22,065 New
ICMH
41
Integrity Capital Management (HK)
Hong Kong
$12K +$12.4K +18,450 New
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$8K – – –
SG
43
StoneX Group
New York
$7.99K +$8.12K +12,110 New
AC
44
Antara Capital
New York
$3K – – –
BCM
45
BlueCrest Capital Management
Jersey
– -$70K -102,814 Closed
AC
46
Athanor Capital
New York
– -$702K -72,363 Closed
UBS Group
47
UBS Group
Switzerland
– -$448 -668 -68%
1
2

AONCW Hedge Fund Activity: Q4 2021 in Review

45 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Warrant (AONCW) for Q4 2021, worth a combined $5.19M — down 0.84% from $5.24M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new AONCW positions and 2 closed out — a net gain of 8 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $126K. The largest seller was Athanor Capital, exiting entirely with an estimated $702K sold.

  • 45 institutional investors held American Oncology Network, Inc. Warrant (AONCW) as of Q4 2021, up from 37 in Q3 2021.
  • Funds reported $5.19M of American Oncology Network, Inc. Warrant stock for Q4 2021, down 0.84% quarter-over-quarter.
  • 10 funds opened new American Oncology Network, Inc. Warrant positions in Q4 2021 and 2 closed out, a net change of +8 holders.
  • The largest American Oncology Network, Inc. Warrant buyer in Q4 2021 was Citadel Advisors, an estimated $126K added.
  • The largest American Oncology Network, Inc. Warrant seller in Q4 2021 was Athanor Capital, an estimated $702K sold.

Based on aggregated 13F filings for Q4 2021.